Mata-McMurry Lina I, Phillips Jennifer V, Burks Sandra G, Greene Adam, Syed Sana, Johnston Karen C
integrated Translational Health Research Institute of Virginia (iTHRIV), University of Virginia, Charlottesville, VA, United States of America.
Department of Pediatrics, University of Virginia, Charlottesville, VA, United States of America.
medRxiv. 2023 Nov 7:2023.11.02.23297785. doi: 10.1101/2023.11.02.23297785.
Historically underrepresented groups in biomedical research have continued to experience low representation despite shifting demographics. Diversity fosters inclusive, higher quality, and innovative team science. One avenue for diversifying research teams is integrating diversity-focused initiatives into Clinical and Translational Science Award (CTSA) Programs, such as the integrated Translational Health Research Institute of Virginia (iTHRIV). In 2020, iTHRIV participated in Building Up, developed by the University of Pittsburgh CTSA, intended to increase representation and improve career support for underrepresented groups in the biomedical workforce. Drawing lessons from this study, iTHRIV implemented the "inspiring Diverse Researchers in Virginia" (iDRIV) program. This year-long program provided education, coaching, mentoring, and sponsorship for underrepresented early-career investigators in the biomedical workforce. To date, 24 participants have participated in the program across three cohorts. Participants have been predominantly female (92%), with 33% identifying as Hispanic/Latinx, 29% as Black, and 13% Asian. Notably, 38% of scholars have subsequently achieved at least one accomplishment, such as receiving a local research honor or award and an extramural funding award from a foundation or federal agency. The iTHRIV iDRIV program serves as a model for providing career support to developing investigators from underrepresented backgrounds, with the overall goal of improving patient health.
在生物医学研究中,历史上代表性不足的群体尽管人口结构发生了变化,但仍然代表性较低。多元化促进了包容性、更高质量和创新性的团队科学。使研究团队多元化的一个途径是将以多元化为重点的举措纳入临床和转化科学奖(CTSA)项目,比如弗吉尼亚综合转化健康研究所(iTHRIV)。2020年,iTHRIV参与了由匹兹堡大学CTSA开发的“发展壮大”项目,旨在增加生物医学劳动力中代表性不足群体的代表性并改善对他们的职业支持。从这项研究中吸取经验教训后,iTHRIV实施了“激励弗吉尼亚州多样化研究人员”(iDRIV)项目。这个为期一年的项目为生物医学劳动力中代表性不足的早期职业研究人员提供教育、辅导、指导和赞助。到目前为止,已有24名参与者分三个队列参加了该项目。参与者主要为女性(92%),其中33%为西班牙裔/拉丁裔,29%为黑人,13%为亚洲人。值得注意的是,38%的学者随后至少取得了一项成就,比如获得当地研究荣誉或奖项以及来自基金会或联邦机构的校外资助奖项。iTHRIV的iDRIV项目为向背景代表性不足的研究人员提供职业支持树立了典范,其总体目标是改善患者健康。